Headache teleconsultation in the era of COVID-19: Patients' evaluation and future directions.
COVID-19
primary headache
satisfaction
telemedicine
Journal
European journal of neurology
ISSN: 1468-1331
Titre abrégé: Eur J Neurol
Pays: England
ID NLM: 9506311
Informations de publication
Date de publication:
11 2021
11 2021
Historique:
received:
19
04
2021
accepted:
05
05
2021
pubmed:
16
5
2021
medline:
27
10
2021
entrez:
15
5
2021
Statut:
ppublish
Résumé
Literature regarding headache teleconsultation and patient satisfaction is scarce. The SARS-CoV-2 pandemic led to the restructuring of traditional clinical activity by adopting telemedicine. Our objectives were to evaluate patients' satisfaction with headache teleconsultation by telephone during the SARS-CoV-2 pandemic and assess patients' preferred model of appointment (face-to-face, teleconsultation by telephone, or both). Patients with a previous diagnosis of primary headache or neuropathies and facial pain disorders, and at least one telephone headache visit during the first wave of COVID-19, filled out an online questionnaire regarding sociodemographic parameters, satisfaction with teleconsultation, and preferred model of appointment. We included 83 patients (valid response rate of 64.3%); most had migraine (83.1%). Regarding teleconsultation, 81.9% considered this model adequate for follow-up, 88.0% were satisfied with the information provided about the disease/treatment, and 73.5% were satisfied with the medication modification. Ninety percent would agree with a new tele-evaluation if stable after the pandemic. The mixed model was the preferred medical consultation type for the postpandemic period (43.4%), followed by face-to-face visits (33.7%). Patients were satisfied with the headache teleconsultation during the COVID-19 era. However, an exclusive model of telemedicine does not seem suitable for monitoring all patients. A mixed approach could be integrated into clinical practice after the pandemic to optimize health care.
Sections du résumé
BACKGROUND AND PURPOSE
Literature regarding headache teleconsultation and patient satisfaction is scarce. The SARS-CoV-2 pandemic led to the restructuring of traditional clinical activity by adopting telemedicine. Our objectives were to evaluate patients' satisfaction with headache teleconsultation by telephone during the SARS-CoV-2 pandemic and assess patients' preferred model of appointment (face-to-face, teleconsultation by telephone, or both).
METHODS
Patients with a previous diagnosis of primary headache or neuropathies and facial pain disorders, and at least one telephone headache visit during the first wave of COVID-19, filled out an online questionnaire regarding sociodemographic parameters, satisfaction with teleconsultation, and preferred model of appointment.
RESULTS
We included 83 patients (valid response rate of 64.3%); most had migraine (83.1%). Regarding teleconsultation, 81.9% considered this model adequate for follow-up, 88.0% were satisfied with the information provided about the disease/treatment, and 73.5% were satisfied with the medication modification. Ninety percent would agree with a new tele-evaluation if stable after the pandemic. The mixed model was the preferred medical consultation type for the postpandemic period (43.4%), followed by face-to-face visits (33.7%).
CONCLUSIONS
Patients were satisfied with the headache teleconsultation during the COVID-19 era. However, an exclusive model of telemedicine does not seem suitable for monitoring all patients. A mixed approach could be integrated into clinical practice after the pandemic to optimize health care.
Identifiants
pubmed: 33991365
doi: 10.1111/ene.14915
pmc: PMC8239939
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
3798-3804Informations de copyright
© 2021 European Academy of Neurology.
Références
Eur J Neurol. 2021 Nov;28(11):3798-3804
pubmed: 33991365
Neurology. 2017 Jul 11;89(2):153-162
pubmed: 28615434
Injury. 2020 Dec;51(12):2816-2821
pubmed: 32951916
Eur J Neurol. 2017 Jun;24(6):807-815
pubmed: 28432757
Telemed J E Health. 2004 Winter;10(4):449-54
pubmed: 15689649
Headache. 2020 May;60(5):833-842
pubmed: 32227596
Pain. 2020 May;161(5):889-893
pubmed: 32251203
J Neurol Sci. 2020 Jul 15;414:116930
pubmed: 32460041
Neurologia (Engl Ed). 2020 Jul - Aug;35(6):372-380
pubmed: 32561333
Cephalalgia. 2018 Jan;38(1):1-211
pubmed: 29368949
Headache. 2020 Nov;60(10):2192-2201
pubmed: 33063855
J Pain. 2017 Feb;18(2):200-211
pubmed: 27838498
Cephalalgia. 2017 Aug;37(9):855-863
pubmed: 27301460
Curr Allergy Asthma Rep. 2020 Sep 22;20(11):72
pubmed: 32959158
Neurology. 2020 Jan 7;94(1):30-38
pubmed: 31801829
Telemed J E Health. 2014 May;20(5):473-7
pubmed: 24617919
Neurology. 2018 May 8;90(19):e1702-e1705
pubmed: 29626180
J Pediatr Health Care. 2018 Sep - Oct;32(5):500-506
pubmed: 29661616
J Med Internet Res. 2016 May 30;18(5):e140
pubmed: 27241876
Medicine (Baltimore). 2018 Mar;97(9):e9891
pubmed: 29489688
Int J Nurs Stud Adv. 2020 Nov;2:100008
pubmed: 33083791
Cephalalgia. 2019 Oct;39(12):1577-1585
pubmed: 31450969